Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

Clinical trial NCT06450067 · RECRUITING

Trial details

NCT number: NCT06450067
Sponsor: Juventas Cell Therapy Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2024-06-05
Primary completion: 2026-06-05
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.